BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15320975)

  • 1. Selective occurrence of ras mutations in benign and malignant thyroid follicular neoplasms in Taiwan.
    Liu RT; Hou CY; You HL; Huang CC; Hock-Liew ; Chou FF; Wang PW; Cheng JT
    Thyroid; 2004 Aug; 14(8):616-21. PubMed ID: 15320975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific pattern of RAS oncogene mutations in follicular thyroid tumors.
    Vasko V; Ferrand M; Di Cristofaro J; Carayon P; Henry JF; de Micco C
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2745-52. PubMed ID: 12788883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability of Ha-ras (codon 12) proto-oncogene mutations in diverse thyroid cancers.
    Bouras M; Bertholon J; Dutrieux-Berger N; Parvaz P; Paulin C; Revol A
    Eur J Endocrinol; 1998 Aug; 139(2):209-16. PubMed ID: 9724079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Point mutations of ras oncogenes are an early event in thyroid tumorigenesis.
    Namba H; Rubin SA; Fagin JA
    Mol Endocrinol; 1990 Oct; 4(10):1474-9. PubMed ID: 2283998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Ras mutations in thyroid neoplasia.
    Esapa CT; Johnson SJ; Kendall-Taylor P; Lennard TW; Harris PE
    Clin Endocrinol (Oxf); 1999 Apr; 50(4):529-35. PubMed ID: 10468914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma.
    Nikiforova MN; Lynch RA; Biddinger PW; Alexander EK; Dorn GW; Tallini G; Kroll TG; Nikiforov YE
    J Clin Endocrinol Metab; 2003 May; 88(5):2318-26. PubMed ID: 12727991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The associations between RAS mutations and clinical characteristics in follicular thyroid tumors: new insights from a single center and a large patient cohort.
    Fukahori M; Yoshida A; Hayashi H; Yoshihara M; Matsukuma S; Sakuma Y; Koizume S; Okamoto N; Kondo T; Masuda M; Miyagi Y
    Thyroid; 2012 Jul; 22(7):683-9. PubMed ID: 22650231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of mutations of ras and p53 in benign and malignant thyroid tumors from children exposed to radiation after the Chernobyl nuclear accident.
    Nikiforov YE; Nikiforova MN; Gnepp DR; Fagin JA
    Oncogene; 1996 Aug; 13(4):687-93. PubMed ID: 8761289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ha-ras oncogene (codon 12) mutation in thyroid carcinogenesis: analysis of 60 benign and malignant thyroid tumors.
    Bouras M; Parvaz P; Berger N; Paulin C; Revol A
    Ann Biol Clin (Paris); 1995; 53(10-11):549-55. PubMed ID: 8787281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive survey of HRAS, KRAS, and NRAS mutations in proliferative thyroid lesions from an ethnically diverse population.
    Schulten HJ; Salama S; Al-Ahmadi A; Al-Mansouri Z; Mirza Z; Al-Ghamdi K; Al-Hamour OA; Huwait E; Gari M; Al-Qahtani MH; Al-Maghrabi J
    Anticancer Res; 2013 Nov; 33(11):4779-84. PubMed ID: 24222113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ras oncogene mutations in benign and malignant thyroid neoplasms.
    Karga H; Lee JK; Vickery AL; Thor A; Gaz RD; Jameson JL
    J Clin Endocrinol Metab; 1991 Oct; 73(4):832-6. PubMed ID: 1890154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Specific amplification by PCR for N-ras mutation in thyroid follicular cartinoma].
    Taniyama M; Kaihara M
    Nihon Rinsho; 1994 Apr; 52(4):1075-80. PubMed ID: 8196166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective activation of ras oncogenes in follicular and undifferentiated thyroid carcinomas.
    Manenti G; Pilotti S; Re FC; Della Porta G; Pierotti MA
    Eur J Cancer; 1994; 30A(7):987-93. PubMed ID: 7946598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ras oncogene mutations in thyroid tumors: polymerase chain reaction-restriction-fragment-length polymorphism analysis from paraffin-embedded tissues.
    Capella G; Matias-Guiu X; Ampudia X; de Leiva A; Perucho M; Prat J
    Diagn Mol Pathol; 1996 Mar; 5(1):45-52. PubMed ID: 8919545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific PCR amplification for N-ras mutations in neoplastic thyroid diseases.
    Kaihara M; Taniyama M; Tadatomo J; Tobe T; Tomita M; Ito K; Ban Y; Katagiri T
    Endocr J; 1994 Jun; 41(3):301-8. PubMed ID: 7951583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H-RAS 81 polymorphism is significantly associated with aneuploidy in follicular tumors of the thyroid.
    Castro P; Soares P; Gusmão L; Seruca R; Sobrinho-Simões M
    Oncogene; 2006 Aug; 25(33):4620-7. PubMed ID: 16532025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-ras mutation of thyroid tumor with special reference to the follicular type.
    Oyama T; Suzuki T; Hara F; Iino Y; Ishida T; Sakamoto A; Nakajima T
    Pathol Int; 1995 Jan; 45(1):45-50. PubMed ID: 7704243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetic study comparing follicular variant versus classic papillary thyroid carcinomas: association of N-ras mutation in codon 61 with follicular variant.
    Di Cristofaro J; Marcy M; Vasko V; Sebag F; Fakhry N; Wynford-Thomas D; De Micco C
    Hum Pathol; 2006 Jul; 37(7):824-30. PubMed ID: 16784981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aneuploidy and RAS mutations are mutually exclusive events in the development of well-differentiated thyroid follicular tumours.
    Banito A; Pinto AE; Espadinha C; Marques AR; Leite V
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):706-11. PubMed ID: 17651453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-ras 61 oncogene mutations in Hürthle cell tumors.
    Schark C; Fulton N; Jacoby RF; Westbrook CA; Straus FH; Kaplan EL
    Surgery; 1990 Dec; 108(6):994-9; discussion 999-1000. PubMed ID: 2247846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.